Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1, HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog, FGF19, Fibroblast growth factor 19
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
;
3265
;
9965
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
APR-246
Sensitive: D – Preclinical
APR-246
Sensitive
:
D
APR-246
Sensitive: D – Preclinical
APR-246
Sensitive
:
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
erdafitinib
Sensitive: D – Preclinical
erdafitinib
Sensitive
:
D
erdafitinib
Sensitive: D – Preclinical
erdafitinib
Sensitive
:
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
INNO-406
Sensitive: D – Preclinical
INNO-406
Sensitive
:
D
INNO-406
Sensitive: D – Preclinical
INNO-406
Sensitive
:
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.